New CEO Daniel Hamburger says Provation Medical is reaching an "inflection point" as the Minneapolis-based health care software firm launches new products, pursues new markets and weighs acquisitions.
Hamburger, who has three decades of technology leadership experience in education, health care and other industries, joined Provation in November. Former CEO Dave Del Toro continues with the company as an executive board member after 20 years at Provation.
Setting the stage for Provation to reach "the next level of acceleration," Hamburger said, is its emergence as an independent company after its March 2018 acquisition by Santa Monica, Calif.-based Clearlake Capital Group from Wolters Kluwer.
"The potential is very high for the growth to continue in the U.S. as well as internationally, driven both by our own internal investments or organic growth as well as acquisition-driven growth," Hamburger said.
Doctors and nurses in more than 1,500 hospitals and 1,000 surgery centers use Provation's software to document procedures as they perform them. It saves five to 10 minutes per procedure compared with dictating or writing a report, Hamburger said, enabling clinicians to serve more patients.
New Provation products focus on specialties like cardiology, orthopedics and pain management, building on the company's leading position in gastrointestinal endoscopy procedure documentation, Hamburger said. Clinicians in 42 of the top 50 hospitals specializing in those procedures use Provation's software.
Platforms for practice management and electronic medical records are on the way, Hamburger said. Surgery centers, which have been slower to adopt those, represent primary markets for expansion.
Also fueling growth is Provation Apex, a cloud-based documentation product that launched last year, Hamburger said, as an alternative to its licensed software.